Acrivon Therapeutics, Inc.(ACRV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ACRV Acrivon Therapeutics, Inc.

未开盘 11-25 16:00:00 EST

7.16

+0.61

+9.31%

盘后7.16

+0.000.00%

16:02 EST

最高7.21	最低6.61	成交量8.43万
今开6.61	昨收6.55	日振幅9.16%
总市值2.23亿	流通市值7,792万	总股本3,114万
成交额59.44万	换手率0.77%	流通股本1,088万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ACRV","market":"US","secType":"STK","nameCN":"Acrivon Therapeutics, Inc.","latestPrice":7.16,"timestamp":1732568400000,"preClose":6.55,"halted":0,"volume":84319,"hourTrading":{"tag":"盘后","latestPrice":7.16,"preClose":7.16,"latestTime":"16:02 EST","volume":7339,"amount":52547.24,"timestamp":1732568574601},"delay":0,"floatShares":10882007,"shares":31136296,"eps":-2.582457,"marketStatus":"未开盘","marketStatusCode":0,"change":0.61,"latestTime":"11-25 16:00:00 EST","open":6.61,"high":7.21,"low":6.61,"amount":594432.558386,"amplitude":0.091603,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.582457,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732611600000},"adr":0,"listingDate":1668488400000,"adjPreClose":6.55,"postHourTrading":{"tag":"盘后","latestPrice":7.16,"preClose":7.16,"latestTime":"16:02 EST","volume":7339,"amount":52547.24,"timestamp":1732568574601},"volumeRatio":2.086567},"requestUrl":"/m/hq/s/ACRV","defaultTab":"news","newsList":[{"id":"2486303542","title":"Acrivon Therapeutics, Inc.盘中异动 股价大涨5.65%报6.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486303542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486303542?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:49","pubTimestamp":1732546144,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时49分，Acrivon Therapeutics, Inc.股票出现波动，股价大幅上涨5.65%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.32%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125224904a2549600&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125224904a2549600&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACRV","LENZ","BK4139"],"gpt_icon":0},{"id":"2484053326","title":"Acrivon Therapeutics, Inc.盘中异动 临近午盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484053326","media":"市场透视","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484053326?lang=zh_cn&edition=full","pubTime":"2024-11-19 00:50","pubTimestamp":1731948618,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日00时50分，Acrivon Therapeutics, Inc.股票出现波动，股价急速下跌5.03%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111900501898e434fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111900501898e434fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACRV","LENZ"],"gpt_icon":0},{"id":"2483530486","title":"Acrivon Therapeutics, Inc.2024财年第三财季实现净利润-22.44百万美元，同比减少55.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483530486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483530486?lang=zh_cn&edition=full","pubTime":"2024-11-16 08:02","pubTimestamp":1731715360,"startTime":"0","endTime":"0","summary":"11月16日，Acrivon Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-22.44百万美元，同比减少55.08%；其中营业收入为0.00美元，每股基本收益为-0.59美元。机构评级：截至2024年11月16日，当前有9家机构对Acrivon Therapeutics, Inc.目标价做出预测，其中目标均价为21.56美元，其中最低目标价为16.00美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116080241abc5e514&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116080241abc5e514&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ACRV"],"gpt_icon":0},{"id":"2483050876","title":"美国研究综述-思科、Freshpet、Nvidia","url":"https://stock-news.laohu8.com/highlight/detail?id=2483050876","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483050876?lang=zh_cn&edition=full","pubTime":"2024-11-14 20:06","pubTimestamp":1731585982,"startTime":"0","endTime":"0","summary":"美国研究综述-思科、Freshpet、Nvidia路透11月14日 - 华尔街证券分析师周四调整了对思科、Freshpet 和 Nvidia 等几家美国上市公司的评级和目标价。要闻 * 思科CSCO.O：杰富瑞将目标价从53美元上调至66美元 * Freshpet Inc FRPT.O：奥本海默将目标价从155美元上调至180美元  * ICU Medical Inc ICUI.O：Raymond James将目标价从190美元上调至205美元  * Kronos Bio Inc KRON.O：TD Cowen将目标价从买入下调至持有 * Nvidia Corp NVDA.O：奥本海默将目标价从 150 美元上调至 175 美元 以下是路透周四报导的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4T3ML18A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNNE","ALLO","LU2106854487.HKD","APD","BK4209","BTMD","LU0868494708.USD","FDMT","CPB","ALSN","LU1244550577.SGD","BWXT","AXTA","CAVA","COGT","LU0234572021.USD","SLRN","SPRY","CRVS","BPMC","AZTA","AIT","AMGN","APEI","LU0300736492.USD","ALMS","LU1894683348.USD","CHGG","AVB","CAKE","CPT","BIIB","CBSH","LU1244550494.USD","CPAY","BRBR","ACRV","AESI","AROC","CTRA","CSCO","IE00BFXG1179.USD","EE","DOX","IE00BZ1G4Q59.USD","BKR","CHX","SG9999002232.USD","BK4550","ADAP"],"gpt_icon":0},{"id":"2460736031","title":"Acrivon Therapeutics, Inc.2024财年第二财季实现净利润-18.80百万美元，同比减少35.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460736031","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460736031?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:04","pubTimestamp":1723910669,"startTime":"0","endTime":"0","summary":"8月18日，Acrivon Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-18.80百万美元，同比减少35.15%；其中营业收入为0.00美元，每股基本收益为-0.52美元。机构评级：截至2024年8月18日，当前有8家机构对Acrivon Therapeutics, Inc.目标价做出预测，其中目标均价为22.00美元，其中最低目标价为17.00美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180007079f3407f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180007079f3407f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ACRV"],"gpt_icon":0},{"id":"2450537167","title":"Acrivon Therapeutics, Inc.盘中异动 早盘大幅下跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450537167","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450537167?lang=zh_cn&edition=full","pubTime":"2024-07-12 23:23","pubTimestamp":1720797833,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日23时23分，Acrivon Therapeutics, Inc.股票出现波动，股价急速下挫5.44%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.57%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712232353aef97dd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712232353aef97dd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACRV","LENZ","BK4139"],"gpt_icon":0},{"id":"2450043361","title":"Acrivon Therapeutics, Inc.盘中异动 股价大涨5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450043361","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450043361?lang=zh_cn&edition=full","pubTime":"2024-07-11 23:03","pubTimestamp":1720710181,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日23时03分，Acrivon Therapeutics, Inc.股票出现异动，股价大幅拉升5.59%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711230302941f6508&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711230302941f6508&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ACRV"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.acrivon.com","stockEarnings":[{"period":"1week","weight":0.1419},{"period":"1month","weight":-0.1005},{"period":"3month","weight":-0.22},{"period":"6month","weight":-0.0453},{"period":"1year","weight":0.8646},{"period":"ytd","weight":0.4553}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Acrivon Therapeutics, Inc.于2018年3月在特拉华州注册成立。该公司是一家临床阶段生物制药公司，开发精确的肿瘤药物，该公司利用其专有的基于蛋白质组学的患者应答者识别平台，将其与肿瘤预测对每种特定药物敏感的患者相匹配。该公司通过使用其专有的精密药物平台AP3来开发其候选肿瘤药物管道。（该公司的AP3平台能够创建药物专用专有OncoSignature伴随诊断，用于识别最有可能从该公司候选药物中获益的患者，该公司称之为患者应答者）。","exchange":"NASDAQ","name":"Acrivon Therapeutics, Inc.","nameEN":"Acrivon Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Acrivon Therapeutics, Inc.(ACRV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Acrivon Therapeutics, Inc.(ACRV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Acrivon Therapeutics, Inc.,ACRV,Acrivon Therapeutics, Inc.股票,Acrivon Therapeutics, Inc.股票老虎,Acrivon Therapeutics, Inc.股票老虎国际,Acrivon Therapeutics, Inc.行情,Acrivon Therapeutics, Inc.股票行情,Acrivon Therapeutics, Inc.股价,Acrivon Therapeutics, Inc.股市,Acrivon Therapeutics, Inc.股票价格,Acrivon Therapeutics, Inc.股票交易,Acrivon Therapeutics, Inc.股票购买,Acrivon Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Acrivon Therapeutics, Inc.(ACRV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Acrivon Therapeutics, Inc.(ACRV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}